Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disulfide bonds are critical covalent linkages that stabilize the three-dimensional structure of mucin glycoproteins and the extracellular polymeric substances (EPS) of bacterial biofilms (Thornton et al., 2008, PubMed). In the respiratory tract, these bonds cross-link mucin monomers into a dense, viscoelastic gel that traps pathogens; however, in diseases like cystic fibrosis and chronic obstructive pulmonary disease (COPD), excessive cross-linking leads to pathologically thick mucus (Fahy & Dickey, 2010, NEJM). Similarly, disulfide bonds within the biofilm matrix contribute to the structural integrity and antibiotic resistance of bacterial communities by anchoring proteins and polysaccharides (Zhao & Liu, 2010, PubMed). Therapeutic intervention typically involves thiol-containing reducing agents, such as N-acetylcysteine (NAC), which break these bonds through thiol-disulfide exchange (StatPearls, 2023). This process reduces the viscosity of mucus, facilitating mucociliary clearance, and destabilizes biofilms to enhance the penetration and efficacy of co-administered antibiotics (Olofsson et al., 2003, Applied and Environmental Microbiology). Targeting these chemical bonds remains a cornerstone strategy for managing obstructive airway diseases and persistent microbial infections.
Thiol-disulfide exchange reaction resulting in the reduction of covalent disulfide cross-links into free sulfhydryl groups, causing depolymerization of the macromolecular matrix (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disulfide bonds in mucin and bacterial biofilm extracellular matrix.